Skip to main content
. 2019 Feb 26;17(1):1559325819829543. doi: 10.1177/1559325819829543

Table 3.

Univariate and Multivariate Logistic Regression Analyses of Resectable Cervical Cancer Risk Factors.

Risk Factors Overall Survival (PFS)
Univariate Analysis Multivariate Analysis
OR (95% CI) P Value OR (95% CI) P Value
Age (>51.5 or ≤51.5 years) 1.046 (0.700-1.562) 0.630
Tumor size (> 4 or ≤ 4), cm 1.561 (1.039-2.346) 0.032a 1.424 (0.913-2.222) .119
Lymphonodus metastasis (have or none) 1.104 (0.738-1.652) 0.630
FIGO stage (II or I) 1.615 (1.076-2.424) 0.021a 1.709 (1.114-2.621) .121
Differentiation (moderately, poorly or highly) 1.720 (1.142-2.592) 0.009b 1.682 (1.048-2.700) .014a
Pretreatment CRP level (>2.62 or ≤2.62), mg/L 1.721 (1.148-2.581) 0.009b 1.682 (1.048-2.700) .031a
Pretreatment ALB level (≤42.1 or > 42.1), g/L 0.860 (0.575-1.287) 0.463
Pretreatment GLB level (>27.7 or ≤27.7), g/L 0.919 (0.615-1.373) 0.680
Pretreatment LDH level (>193 or ≤193), U/L 1.656 (1.107-2.478) 0.014a 1.759 (1.155-2.678) .009b
Pretreatment AGR level (>1.47 or ≤1.47) 1.077 (0.721-1.609) 0.716
Post/preradiotherapy CRP ratio (>1 or ≤1) 1.773 (1.179-2.665) 0.006b 1.410 (0.875-2.272) .158
Post/preradiotherapy ALB ratio (>1 or ≤1) 0.835 (0.559-1.247) 0.379
Post/preradiotherapy GLB ratio (>1 or ≤1) 0.516 (0.585-1.309) 0.516
Post/preradiotherapy LDH ratio (>1 or ≤1) 1.839 (1.204-2.810) 0.005b 1.514 (0.948-2.418) .080
Post/preradiotherapy AGR ratio (>1 or ≤1) 0.748 (0.500-1.121) 0.159
Post/pretreatment CRP ratio (>1 or ≤1) 1.576 (1.050-2.367) 0.028a 1.423 (0.866-2.338) .164
Post/pretreatment ALB ratio (>1 or ≤1) 0.978 (0.657-1.482) 0.950
Post/pretreatment GLB ratio (>1 or ≤1) 1.055 (0.706-1.578) 0.793
Post/pretreatment LDH ratio (>1 or ≤1) 1.032 (0.689-1.261) 1.544
Post/pretreatment AGR ratio (>1 or ≤1) 0.805 (0.536-1.207) 0.293

Abbreviation: AGR, albumin-to-globulin ratio; ALB, albumin; CRP, C-reactive protein; CI, confidence interval; FIGO, Federation of Gynecology and Obstetrics; GLB, globulin; LDH, lactate dehydrogenase; OR, odds ratio; PFS, progression-free survival.

aP < .05.

bP < .01.